usfda

  1. H

    Alembic Pharmaceuticals Receives USFDA Approval for Paroxetine Tablet

    Alembic Pharmaceuticals Secures USFDA Approval for Generic Paroxetine Extended-Release Tablets Approval Strengthens Alembic’s US Generics Portfolio New Delhi, March 30: Alembic Pharmaceuticals Ltd on Monday announced that it has received final approval from the United States Food and Drug...
  2. H

    Pharmaceuticals: India's Expanding Role in Global Healthcare

    India’s Pharmaceutical Industry Strengthens Global Position, Eyes $130 Billion Market by 2030 Sector Ranks Third Globally by Volume with Expanding Manufacturing Base New Delhi, March 21: India’s pharmaceutical industry continues to solidify its position as a globally integrated and...
  3. K

    Lupin Secures USFDA Approval for Generic Brivaracetam Oral Solution, Launches in US Market

    Lupin Receives USFDA Nod for Seizure Treatment Drug Mumbai based pharmaceutical major Lupin Ltd on Wednesday announced that it has received approval from the U.S. Food and Drug Administration to market a generic medication used in the treatment of seizures in the United States.The approval...
Back
Top